Travere Therapeutics Stock (NASDAQ: TVTX) stock price, news, charts, stock research, profile.
Open | $15.36 |
Close | - |
Volume / Avg. | 177.23K / 1.46M |
Day Range | $14.82 - $15.36 |
52 Wk Range | 5.12 - 15.26 |
Market Cap | $1.14B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 80 |
Short Interest | 13.6% |
Days to Cover | 13.34 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Travere Therapeutics (NASDAQ:TVTX) through any online brokerage.
Other companies in Travere Therapeutics’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT) and Immatics (NASDAQ:IMTX).
Travere Therapeutics has a consensus price target of $21.41.
The stock price for Travere Therapeutics (NASDAQ: TVTX) is $14.91 last updated September 23, 2024 at 11:15 AM EDT.
There are no upcoming dividends for Travere Therapeutics.
Travere Therapeutics’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Travere Therapeutics.
Travere Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.